{
  "docId": "019dd923-5fec-763b-95ce-df36eb136cb7",
  "docSlug": "v2M0U9ih51yxmXlSsD1M",
  "documentTitle": "See the pitch deck a psychedelics startup just used to raise $18.6 million to develop new treatments derived from the Sonoran Desert toad",
  "authorId": "Pitchdecks",
  "authorName": "Beckley Psytech",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "strategy_consulting",
  "sourceTypeLabel": "Strategy consulting",
  "presentationDate": null,
  "orientation": "landscape",
  "aspectRatio": 1.777,
  "pageNumber": 5,
  "pageCount": 22,
  "prevPage": 4,
  "nextPage": 6,
  "slideType": "executive_summary",
  "function": "summarize",
  "density": "balanced",
  "nDataPoints": 1,
  "notes": "The slide uses a honeycomb/hexagonal layout to present four key pillars of the business.",
  "elementsJson": [
    "headline_text",
    "numbered_list",
    "other"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-5fec-763b-95ce-df36eb136cb7/5",
  "deckHref": "/decks/019dd923-5fec-763b-95ce-df36eb136cb7",
  "deckJsonHref": "/decks/019dd923-5fec-763b-95ce-df36eb136cb7.json",
  "deckAnchorHref": "/decks/019dd923-5fec-763b-95ce-df36eb136cb7#slide-5",
  "components": [
    {
      "bbox": {
        "h": 0.7,
        "w": 0.9,
        "x": 0.05,
        "y": 0.2
      },
      "kind": "list",
      "text": "01: Developing psychedelic compounds as a transformative new class of medicine for neuropsychiatric diseases. 02: Team combines unmatched psychedelic research and drug development expertise and has proven track-record of success in biotech startups. 03: Drug development platform approach to manage risk and maximise commercial value. 04: Company is raising $18m to advance core programs through key development milestones as set out in this presentation.",
      "attrs": null,
      "subkind": "numbered",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "bebee16e-d5fc-4205-86bf-9ad47df96ff4",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.94,
        "x": 0.03,
        "y": 0.04
      },
      "kind": "title",
      "text": "Beckley Psytech: A leading Psychedelic Drug Development Platform positioned for significant growth",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4b9850f7-2b22-4e24-9048-72ae493600e4",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Executive summary",
      "slug": "executive-summary",
      "agent": null,
      "layer": "slide",
      "matchId": "5ebb2e79-3ce8-4a39-b6e3-ef9b190f2fb4",
      "evidence": "Beckley Psytech: A leading Psychedelic Drug Development Platform positioned for significant growth",
      "confidence": 0.9
    }
  ],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}